McKesson Corporation (FRA:MCK)

Market Cap	80.77B
Revenue (ttm)	321.52B
Net Income (ttm)	2.69B
Shares Out	n/a
EPS (ttm)	21.25
PE Ratio	29.98
Forward PE	19.40
Dividend	2.68 (0.43%)
Ex-Dividend Date	Sep 2, 2025

Volume	n/a
Average Volume	22
Open	647.40
Previous Close	652.60
Day's Range	647.40 - 647.40
52-Week Range	436.00 - 652.60
Beta	n/a
RSI	67.63
Earnings Date	Nov 5, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD